Trinity Biotech

Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation.

Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products.

Today Trinity Biotech is listed on the NASDAQ Global Select Market, and has approximately 18 million American Depository Shares.

The Company, which has its headquarters in Bray, Ireland, employs in excess of 700 people worldwide and markets its portfolio of over 500 products to customers in 80 countries around the world.

Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.